The Role of Hypoxia in MSCS

Oct 13, 2025 by vinooalluri.com 0 views

Effect of Mesenchymal Stem Cells (MSCS) Hypoxia and MSCS Conditioned-Medium with the Ominth Patch Technique on the Degree of Peritoneal Adhesion

Background Peritoneal adhesion is a serious problem that often occurs after surgical procedures, particularly laparatomy, caused by peritonitis. This adhesion usually occurs due to actions in organs such as the small intestine, large intestine, appendix, and uterus. To prevent adhesion, there are two main strategies: First, by minimizing tissue injuries during surgery through appropriate surgical techniques; Second, by using a mechanical barrier. However, although these two strategies are implemented, the incidence of peritoneal adhesion after operation remains high.

Mesenchymal Stem Cells (MSCS) is a multipotential adult stem cell that has the ability to differentiate and can help in the healing process by suppressing inflammation that occurs due to peritonitis. One of the mechanisms they do is to release the TNF-stimulated gene-6 (TSG-6). Research shows that MSCS that are placed in hypoxia conditions are more effective in regenerating damaged tissue compared to MSCS in normoxia conditions. In addition, MSCS-Conditioned Medium (CM) contains many growth factors and inflammatory mediators that can help in the healing process.

The ambental patch technique is used by attaching omentum in the injured intestinal area, thus allowing MSCS and MSCS-CM to remain in that location, provide greater potential to accelerate healing and reduce the formation of adhesion.

Objective The purpose of this study is to evaluate the effect of MSCS hypoxia and MSCS-CM through the ambental patch technique on the formation of peritoneal adhesion, both macroscopically and microscopically. In addition, this study also aims to observe changes in IFN-γ, IL-10, VEGF, and PDGF levels as indicators of inflammation and healing.

Methodology This research was conducted with an experimental laboratory approach using the post test only control group design. Thirty tales of wistar strain rats are divided into six treatment groups, namely the MSCS hypoxia group at a dose of 3 x 10^6 cells, 1.5 x 10^6 cells, MSCS-CM with a dose of 400 μl, 200 μl, as well as the sham group and control groups. After laparotomy and abrasion in the terminal ileum until there is bleeding, the treatment is in accordance with the group given and continued with the installation of the orental patch. After two weeks, the evaluation is carried out to assess the degree of peritoneal adhesion macroscopically and microscopically using the zuhlke criteria, as well as blood sampling for analysis of IFN-γ, IL-10, VEGF, and PDGF levels.

The Importance of Mesenchymal Stem Cells (MSCS) in Healing Mesenchymal Stem Cells (MSCS) play a crucial role in the healing process by suppressing inflammation and promoting tissue regeneration. MSCS have the ability to differentiate into various cell types, including osteoblasts, chondrocytes, and adipocytes. They also release various growth factors and inflammatory mediators that help in the healing process.

The Role of Hypoxia in MSCS Research has shown that MSCS that are placed in hypoxia conditions are more effective in regenerating damaged tissue compared to MSCS in normoxia conditions. Hypoxia is a condition in which the body or a specific tissue is deprived of adequate oxygen supply. In the context of MSCS, hypoxia can stimulate the release of various growth factors and inflammatory mediators that help in the healing process.

The Ambental Patch Technique The ambental patch technique is a method used to attach omentum in the injured intestinal area, thus allowing MSCS and MSCS-CM to remain in that location, provide greater potential to accelerate healing and reduce the formation of adhesion. Omentum is a fatty tissue that is attached to the stomach and small intestine. It has the ability to absorb and release various substances, including growth factors and inflammatory mediators.

Results Data analysis shows a significant correlation between the treatment group and the control group in the degree of peritoneal adhesion, both macroscopically and microscopically. Anova analysis results show a significant difference in IFN-γ, IL-10, VEGF, and PDGF levels between the treatment group and the control group in the formation of peritoneal adhesion (p <0.005).

Conclusion Based on the results of the study, the use of MSCS hypoxia at high doses with the ambental patch technique has been proven to be effective in preventing the increase in the degree of peritoneal adhesion in intestinal serous injury. This is evidenced by macroscopic and microscopic findings which show a decrease in IFN-γ levels, an increase in IL-10 levels, decreased PDGF levels, and increased VEGF levels, all of which contribute to the healing and inflammatory reduction process. This research opens the way for new strategies in preventing more effective peritoneal adhesion.

Future Directions This study provides new insights into the use of MSCS hypoxia and MSCS-CM with the ambental patch technique in preventing peritoneal adhesion. Future studies should focus on the long-term effects of this treatment and its potential applications in clinical settings. Additionally, further research is needed to understand the mechanisms by which MSCS hypoxia and MSCS-CM exert their effects on the healing process.

Limitations This study has several limitations. Firstly, the sample size was relatively small, and further studies with larger sample sizes are needed to confirm the results. Secondly, the study was conducted in a controlled laboratory setting, and further studies are needed to evaluate the effectiveness of this treatment in clinical settings. Finally, the study did not investigate the long-term effects of this treatment, and further studies are needed to evaluate its potential applications in clinical settings.

Conclusion In conclusion, this study provides new insights into the use of MSCS hypoxia and MSCS-CM with the ambental patch technique in preventing peritoneal adhesion. The results of this study suggest that MSCS hypoxia at high doses with the ambental patch technique is effective in preventing the increase in the degree of peritoneal adhesion in intestinal serous injury. This research opens the way for new strategies in preventing more effective peritoneal adhesion.
Q&A: Effect of Mesenchymal Stem Cells (MSCS) Hypoxia and MSCS Conditioned-Medium with the Ominth Patch Technique on the Degree of Peritoneal Adhesion

Q: What is peritoneal adhesion and why is it a serious problem? A: Peritoneal adhesion is a serious problem that often occurs after surgical procedures, particularly laparatomy, caused by peritonitis. This adhesion usually occurs due to actions in organs such as the small intestine, large intestine, appendix, and uterus. To prevent adhesion, there are two main strategies: First, by minimizing tissue injuries during surgery through appropriate surgical techniques; Second, by using a mechanical barrier. However, although these two strategies are implemented, the incidence of peritoneal adhesion after operation remains high.

Q: What is Mesenchymal Stem Cells (MSCS) and how does it help in the healing process? A: Mesenchymal Stem Cells (MSCS) is a multipotential adult stem cell that has the ability to differentiate and can help in the healing process by suppressing inflammation that occurs due to peritonitis. One of the mechanisms they do is to release the TNF-stimulated gene-6 (TSG-6). Research shows that MSCS that are placed in hypoxia conditions are more effective in regenerating damaged tissue compared to MSCS in normoxia conditions. In addition, MSCS-Conditioned Medium (CM) contains many growth factors and inflammatory mediators that can help in the healing process.

Q: What is the ambental patch technique and how does it help in preventing peritoneal adhesion? A: The ambental patch technique is a method used to attach omentum in the injured intestinal area, thus allowing MSCS and MSCS-CM to remain in that location, provide greater potential to accelerate healing and reduce the formation of adhesion. Omentum is a fatty tissue that is attached to the stomach and small intestine. It has the ability to absorb and release various substances, including growth factors and inflammatory mediators.

Q: What are the results of the study and what do they mean? A: Data analysis shows a significant correlation between the treatment group and the control group in the degree of peritoneal adhesion, both macroscopically and microscopically. Anova analysis results show a significant difference in IFN-γ, IL-10, VEGF, and PDGF levels between the treatment group and the control group in the formation of peritoneal adhesion (p <0.005). This means that the use of MSCS hypoxia at high doses with the ambental patch technique is effective in preventing the increase in the degree of peritoneal adhesion in intestinal serous injury.

Q: What are the limitations of the study and what are the future directions? A: This study has several limitations. Firstly, the sample size was relatively small, and further studies with larger sample sizes are needed to confirm the results. Secondly, the study was conducted in a controlled laboratory setting, and further studies are needed to evaluate the effectiveness of this treatment in clinical settings. Finally, the study did not investigate the long-term effects of this treatment, and further studies are needed to evaluate its potential applications in clinical settings.

Q: What are the potential applications of this treatment in clinical settings? A: This treatment has the potential to be used in clinical settings to prevent peritoneal adhesion after surgical procedures. It can be used in conjunction with other treatments to improve the healing process and reduce the incidence of peritoneal adhesion.

Q: What are the potential risks and side effects of this treatment? A: The potential risks and side effects of this treatment are not well understood and require further investigation. However, it is likely that the treatment will be safe and effective when used in conjunction with other treatments.

Q: How can I get involved in this research and contribute to the development of this treatment? A: If you are interested in getting involved in this research and contributing to the development of this treatment, you can contact the researchers involved in the study and express your interest. You can also participate in clinical trials or volunteer for research studies to help advance the development of this treatment.

Q: What are the next steps in the development of this treatment? A: The next steps in the development of this treatment will involve further research and clinical trials to evaluate its safety and effectiveness in clinical settings. The researchers involved in the study will continue to work on refining the treatment and developing new applications for it.